Hang Seng
17660
238 (1.4%)
China A50
11194.6
40 (0.4%)
FTSE 100
8309.86
31 (0.4%)
Nasdaq
17628.1
36 (0.2%)
Dow Jones
41606.2
-16 (-0%)
SP 500
5634.58
1 (0%)
SP 500 VIX
17.61
0 (0%)

廣發證券 的分析報告: (共 75 份)

報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2024-08-02周大福買入6.9410.4155%6.2670%6.036.94
2024-07-23波司登買入3.965.3939%3.644%3.714.04
2024-06-27買入379.6507.5536%36%349397.2
2024-06-26和黃醫藥買入2841.1645%26.548%26.0532.5
2024-06-12阿里巴巴買入0.4350.6855%0.36586%0.350.48
2024-06-07越秀地產買入611.7892%4.31187%3.776.18
2024-04-23特步國際買入4.427.3261%4.5964%4.366.1
2024-04-17三一國際買入5.110.7102%4.27144%3.87.28
2024-04-01海吉亞醫買入3238.8129%14.920%27.0539.052024-05-1645天
2024-02-19買入72.597.1436%22%65.886.3
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2024-01-31買入21.9101.11393%814%10.1422.3
2023-11-24金斯瑞生買入22.834.9655%11.94188%7.4323.6
2023-11-21買入76133.4376%67%64.686.3
2023-08-29英恒科技首次覆蓋3.185.4557%0.97486%1.183.74
2023-08-25吉利汽車買入9.4825.25166%9.29183%7.2410.76
2023-08-09亞盛醫藥買入24.1540.8348%37.925%15.4234.4
2023-08-08固生堂買入45.1571.1764%33.897%32.752.4
2023-07-14越秀地產買入8.7511.7835%4.31187%3.5211.26
2023-04-20微創機器買入26.378.58212%7.291107%6.2926.5
2023-04-19買入94.5216.34135%171%64.6100
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2023-02-25華潤醫療-6.328.5533%3.46154%3.068.36
2023-02-24華潤醫療買入6.688.5535%3.46154%3.068.36
2023-02-03中國海外買入20.730.550%11.52158%10.121.95
2022-11-18買入30039537%0%245.993406.82023-01-2669天
2022-10-03華潤啤酒-54.4570.8129%23.3196%22.1565.6
2022-09-26波司登買入3.836.670%3.676%2.834.89
2022-09-21三一國際買入8.4110.726%4.270%6.410.742023-05-02223天
2022-09-13網龍買入15.736.9135%9.72258%1020.7
2022-09-07微創機器買入25.578.58178%7.291107%6.2938.8
2022-08-19增持330.6370.5811%0%208.2382.42023-01-09143天
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2022-04-14買入62.25101.1159%814%10.1487
2022-04-13三一國際買入810.733%4.270%6.410.742023-05-02384天
2022-04-07華潤醫療買入4.748.5586%3.46154%3.068.36
2022-02-28增持390535.6842%133%208.2404.2
2022-01-28華潤啤酒買入59.570.8121%23.3196%22.1565.6
2022-01-27特步國際買入13.716.1322%4.59267%3.6114.98
2022-01-14商湯-W增持7.18.0818%1.12615%0.587.6
2021-12-28波司登買入4.936.637%3.676%2.835.35
2021-12-28華潤醫療買入4.688.5582%3.46154%3.068.36
2021-12-22敏華控股買入11.6615.2729%4.34255%4.2114.42
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2021-12-13微創機器買入55.978.5842%7.291107%6.2965
2021-12-09平安好醫買入29.2551.871%9.75444%9.1134.2
2021-11-23買入133216.3463%171%60.25135.9
2021-08-10IGGI買入7.8912.558%3.57249%2.028.26
2021-07-30華興資本增持18.7241.86138%2.93300%5.8222.9
2021-07-28吉利汽車買入23.2525.256%9.290%22.0525.72021-07-291天
2021-05-20中國財險-7.4511.0748%10.240%611.362024-03-111026天
2020-06-24申洲國際增持99.6108.711%58.90%89.8109.62020-08-1350天
2020-02-26網龍-21.436.968%9.72258%1026.4
2020-02-14平安好醫買入76.8582.111%9.750%73.182.22020-02-195天
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2019-11-29中國水務買入6.038.6243%4.530%5.058.642021-09-06647天
2019-11-01中國海外買入24.530.521%11.520%24.530.952020-01-0262天
2019-11-01新天綠色買入2.253.0537%3.070%1.243.12021-03-23508天
2019-10-23中國建築買入7.328.817%10.820%4.118.952021-12-06775天
2019-09-18重慶農村買入4.214.7814%3.6730%2.354.44
2019-08-30微盟集團買入4.145.638%1.270%3.065.822020-02-10164天
2019-08-08中國生物買入9.249.95%3.290%8.86102019-08-1911天
2019-05-22買入1013.837%0%8.2813.942020-01-20243天
2019-03-06買入365.23959%0%343.2400.42019-04-1136天
2018-12-25周大福-6.581056%6.260%5.0510.12020-09-08623天
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2018-11-30特步國際增持4.155.941%4.590%3.966.452019-03-13103天
2018-11-13華晨中國持有6.319.7204%2.73529%1.959.79
2018-11-02中國永達增持4.228.6290%1.340%4.128.72020-01-16440天
2018-10-18舜宇光學買入83.112551%45.20%58.55126.12019-09-20337天
2018-10-10吉利汽車買入13.6225.2584%9.290%1026.92020-12-31813天
2018-09-01海螺創業買入27.233.827%5.70%20.35342019-12-31486天
2018-06-15蒙牛乳業買入27.733.8823%13.340%20.934.62019-08-28439天
2018-03-09中國龍工買入3.234.332%1.410%3.014.332018-05-1870天
2016-11-14國銀金租首予1.842.114%1.210%0.882.152024-02-152649天
2016-09-01海昌海洋買入1.62223%0.70%1.552.032017-09-06370天
報告日期股票意見當日收目標目標賺現價離目標最低最高到價日期到價歷時
2016-05-16楓葉教育首予2.946.8131%0.2110%2.0557.12018-05-23737天
2015-03-27首予13.715.714%0%13.717.182015-04-0812天
2013-08-02聯想集團買入7.168.518%9.330%7.078.742013-11-0797天
2013-07-30北京首都增持4.757.760%2.250%4.747.762015-01-16535天
2013-07-29華能國際增持7.7210.735%4.20%6.1211.562014-12-22511天




免責聲明:
本站的所有資料皆從互聯網搜集或轉載或各用戶/股神/估神/燈神的意見, 當中會存在延遲及分析錯誤, 不保證準確, 僅供參考及學術研究。任何因使用本站導致的損失, 本站概不負責。